{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T14:51:28Z","timestamp":1793285488606,"version":"4.5.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T00:00:00Z","timestamp":1665360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T00:00:00Z","timestamp":1665360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"NIH","award":["R21AG065653"],"award-info":[{"award-number":["R21AG065653"]}]},{"name":"NIH","award":["U19AG069701"],"award-info":[{"award-number":["U19AG069701"]}]},{"DOI":"10.13039\/100015013","name":"Florida Department of State","doi-asserted-by":"publisher","award":["9AZ09"],"award-info":[{"award-number":["9AZ09"]}],"id":[{"id":"10.13039\/100015013","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s12035-022-03065-1","type":"journal-article","created":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T12:26:59Z","timestamp":1665404819000},"page":"26-35","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Suppression of Wnt\/\u03b2-Catenin Signaling Is Associated with Downregulation of Wnt1, PORCN, and Rspo2 in Alzheimer\u2019s Disease"],"prefix":"10.1007","volume":"60","author":[{"given":"Jesse R.","family":"Macyczko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxue","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadafumi C.","family":"Ikezu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Chen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guojun","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3489-6362","authenticated-orcid":false,"given":"Yonghe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,10]]},"reference":[{"key":"3065_CR1","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.cell.2017.05.016","volume":"169","author":"R Nusse","year":"2017","unstructured":"Nusse R, Clevers H (2017) Wnt\/beta-catenin signaling, disease, and emerging therapeutic modalities. Cell 169:985\u2013999","journal-title":"Cell"},{"key":"3065_CR2","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1083\/jcb.200303158","volume":"162","author":"L Topol","year":"2003","unstructured":"Topol L, Jiang X, Choi H, Garrett-Beal L, Carolan PJ, Yang Y (2003) Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent beta-catenin degradation. J Cell Biol 162:899\u2013908","journal-title":"J Cell Biol"},{"key":"3065_CR3","doi-asserted-by":"publisher","first-page":"3729","DOI":"10.1038\/emboj.2011.236","volume":"30","author":"H Peradziryi","year":"2011","unstructured":"Peradziryi H, Kaplan NA, Podleschny M, Liu X, Wehner P, Borchers A, Tolwinski NS (2011) PTK7\/Otk interacts with Wnts and inhibits canonical Wnt signalling. EMBO J 30:3729\u20133740","journal-title":"EMBO J"},{"key":"3065_CR4","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.cell.2015.07.013","volume":"162","author":"HW Park","year":"2015","unstructured":"Park HW, Kim YC, Yu B, Moroishi T, Mo JS, Plouffe SW, Meng Z, Lin KC et al (2015) Alternative Wnt signaling activates YAP\/TAZ. Cell 162:780\u2013794","journal-title":"Cell"},{"key":"3065_CR5","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","volume":"71","author":"GS Bloom","year":"2014","unstructured":"Bloom GS (2014) Amyloid-beta and tau: the trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurol 71:505\u2013508","journal-title":"JAMA Neurol"},{"key":"3065_CR6","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13024-020-00391-7","volume":"15","author":"T Guo","year":"2020","unstructured":"Guo T, Zhang D, Zeng Y, Huang TY, Xu H, Zhao Y (2020) Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer\u2019s disease. Mol Neurodegener 15:40","journal-title":"Mol Neurodegener"},{"key":"3065_CR7","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/nrn2755","volume":"11","author":"NC Inestrosa","year":"2010","unstructured":"Inestrosa NC, Arenas E (2010) Emerging roles of Wnts in the adult nervous system. Nat Rev Neurosci 11:77\u201386","journal-title":"Nat Rev Neurosci"},{"key":"3065_CR8","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13041-019-0525-5","volume":"12","author":"L Jia","year":"2019","unstructured":"Jia L, Pina-Crespo J, Li Y (2019) Restoring Wnt\/beta-catenin signaling is a promising therapeutic strategy for Alzheimer\u2019s disease. Mol Brain 12:104","journal-title":"Mol Brain"},{"key":"3065_CR9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13024-021-00474-z","volume":"16","author":"B Bai","year":"2021","unstructured":"Bai B, Vanderwall D, Li Y, Wang X, Poudel S, Wang H, Dey KK, Chen PC et al (2021) Proteomic landscape of Alzheimer\u2019s disease: novel insights into pathogenesis and biomarker discovery. Mol Neurodegener 16:55","journal-title":"Mol Neurodegener"},{"key":"3065_CR10","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.neuron.2014.08.048","volume":"84","author":"CC Liu","year":"2014","unstructured":"Liu CC, Tsai CW, Deak F, Rogers J, Penuliar M, Sung YM, Maher JN, Fu Y et al (2014) Deficiency in LRP6-mediated Wnt signaling contributes to synaptic abnormalities and amyloid pathology in Alzheimer\u2019s disease. Neuron 84:63\u201377","journal-title":"Neuron"},{"key":"3065_CR11","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s12035-018-1103-z","volume":"56","author":"J Folke","year":"2019","unstructured":"Folke J, Pakkenberg B, Brudek T (2019) Impaired Wnt signaling in the prefrontal cortex of Alzheimer\u2019s disease. Mol Neurobiol 56:873\u2013891","journal-title":"Mol Neurobiol"},{"key":"3065_CR12","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1007\/s00702-015-1375-7","volume":"122","author":"J Riise","year":"2015","unstructured":"Riise J, Plath N, Pakkenberg B, Parachikova A (2015) Aberrant Wnt signaling pathway in medial temporal lobe structures of Alzheimer\u2019s disease. J Neural Transm (Vienna) 122:1303\u20131318","journal-title":"J Neural Transm (Vienna)"},{"key":"3065_CR13","doi-asserted-by":"publisher","first-page":"9434","DOI":"10.1073\/pnas.0603523104","volume":"104","author":"GV De Ferrari","year":"2007","unstructured":"De Ferrari GV, Papassotiropoulos A, Biechele T, Wavrant De-Vrieze F, Avila ME, Major MB, Myers A, Saez K et al (2007) Common genetic variation within the low-density lipoprotein receptor-related protein 6 and late-onset Alzheimer\u2019s disease. Proc Natl Acad Sci U S A 104:9434\u20139439","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1709","key":"3065_CR14","first-page":"e1709","volume":"34","author":"MA Alarcon","year":"2013","unstructured":"Alarcon MA, Medina MA, Hu Q, Avila ME, Bustos BI, Perez-Palma E, Peralta A, Salazar P et al (2013) A novel functional low-density lipoprotein receptor-related protein 6 gene alternative splice variant is associated with Alzheimer\u2019s disease. Neurobiol Aging 34(1709):e1709-1718","journal-title":"Neurobiol Aging"},{"key":"3065_CR15","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.neurobiolaging.2022.03.011","volume":"115","author":"Y Li","year":"2022","unstructured":"Li Y, Macyczko JR, Liu CC, Bu G (2022) ApoE4 reduction: an emerging and promising therapeutic strategy for Alzheimer\u2019s disease. Neurobiol Aging 115:20\u201328","journal-title":"Neurobiol Aging"},{"key":"3065_CR16","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13024-020-0358-9","volume":"15","author":"T Williams","year":"2020","unstructured":"Williams T, Borchelt DR, Chakrabarty P (2020) Therapeutic approaches targeting apolipoprotein E function in Alzheimer\u2019s disease. Mol Neurodegener 15:8","journal-title":"Mol Neurodegener"},{"key":"3065_CR17","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13024-020-00413-4","volume":"15","author":"Z Li","year":"2020","unstructured":"Li Z, Shue F, Zhao N, Shinohara M, Bu G (2020) APOE2: protective mechanism and therapeutic implications for Alzheimer\u2019s disease. Mol Neurodegener 15:63","journal-title":"Mol Neurodegener"},{"key":"3065_CR18","doi-asserted-by":"publisher","first-page":"e2004993","DOI":"10.1002\/advs.202004993","volume":"8","author":"HM Chow","year":"2021","unstructured":"Chow HM, Sun JK, Hart RP, Cheng KK, Hung CHL, Lau TM, Kwan KM (2021) Low-density lipoprotein receptor-related protein 6 cell surface availability regulates fuel metabolism in astrocytes. Adv Sci (Weinh) 8:e2004993","journal-title":"Adv Sci (Weinh)"},{"key":"3065_CR19","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/j.1471-4159.2006.03867.x","volume":"98","author":"A Caruso","year":"2006","unstructured":"Caruso A, Motolese M, Iacovelli L, Caraci F, Copani A, Nicoletti F, Terstappen GC, Gaviraghi G et al (2006) Inhibition of the canonical Wnt signaling pathway by apolipoprotein E4 in PC12 cells. J Neurochem 98:364\u2013371","journal-title":"J Neurochem"},{"key":"3065_CR20","doi-asserted-by":"publisher","first-page":"6021","DOI":"10.1523\/JNEUROSCI.1381-04.2004","volume":"24","author":"A Caricasole","year":"2004","unstructured":"Caricasole A, Copani A, Caraci F, Aronica E, Rozemuller AJ, Caruso A, Storto M, Gaviraghi G et al (2004) Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is associated with neuronal degeneration in Alzheimer\u2019s brain. J Neurosci 24:6021\u20136027","journal-title":"J Neurosci"},{"key":"3065_CR21","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1111\/j.1471-4159.2009.06566.x","volume":"112","author":"MC Rosi","year":"2010","unstructured":"Rosi MC, Luccarini I, Grossi C, Fiorentini A, Spillantini MG, Prisco A, Scali C, Gianfriddo M et al (2010) Increased Dickkopf-1 expression in transgenic mouse models of neurodegenerative disease. J Neurochem 112:1539\u20131551","journal-title":"J Neurochem"},{"key":"3065_CR22","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/s41398-018-0231-6","volume":"8","author":"C Elliott","year":"2018","unstructured":"Elliott C, Rojo AI, Ribe E, Broadstock M, Xia W, Morin P, Semenov M, Baillie G et al (2018) A role for APP in Wnt signalling links synapse loss with beta-amyloid production. Transl Psychiatry 8:179","journal-title":"Transl Psychiatry"},{"key":"3065_CR23","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/nrm3470","volume":"13","author":"C Niehrs","year":"2012","unstructured":"Niehrs C (2012) The complex world of WNT receptor signalling. Nat Rev Mol Cell Biol 13:767\u2013779","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3065_CR24","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.pharmthera.2019.02.009","volume":"198","author":"VI Torres","year":"2019","unstructured":"Torres VI, Godoy JA, Inestrosa NC (2019) Modulating Wnt signaling at the root: porcupine and Wnt acylation. Pharmacol Therapeut 198:34\u201345","journal-title":"Pharmacol Therapeut"},{"key":"3065_CR25","doi-asserted-by":"publisher","first-page":"160089","DOI":"10.1038\/sdata.2016.89","volume":"3","author":"M Allen","year":"2016","unstructured":"Allen M, Carrasquillo MM, Funk C, Heavner BD, Zou F, Younkin CS, Burgess JD, Chai HS et al (2016) Human whole genome genotype and transcriptome data for Alzheimer\u2019s and other neurodegenerative diseases. Sci Data 3:160089","journal-title":"Sci Data"},{"key":"3065_CR26","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.jalz.2017.09.012","volume":"14","author":"M Allen","year":"2018","unstructured":"Allen M, Wang X, Burgess JD, Watzlawik J, Serie DJ, Younkin CS, Nguyen T, Malphrus KG et al (2018) Conserved brain myelination networks are altered in Alzheimer\u2019s and other neurodegenerative diseases. Alzheimers Dement 14:352\u2013366","journal-title":"Alzheimers Dement"},{"key":"3065_CR27","doi-asserted-by":"publisher","first-page":"17972","DOI":"10.1074\/jbc.272.29.17972","volume":"272","author":"PM Sullivan","year":"1997","unstructured":"Sullivan PM, Mezdour H, Aratani Y, Knouff C, Najib J, Reddick RL, Quarfordt SH, Maeda N (1997) Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis. J Biol Chem 272:17972\u201317980","journal-title":"J Biol Chem"},{"issue":"727\u2013742","key":"3065_CR28","first-page":"e726","volume":"106","author":"N Zhao","year":"2020","unstructured":"Zhao N, Ren Y, Yamazaki Y, Qiao W, Li F, Felton LM, Mahmoudiandehkordi S, Kueider-Paisley A et al (2020) Alzheimer\u2019s risk factors age, APOE genotype, and sex drive distinct molecular pathways. Neuron 106(727\u2013742):e726","journal-title":"Neuron"},{"key":"3065_CR29","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/s41591-018-0004-z","volume":"24","author":"C Wang","year":"2018","unstructured":"Wang C, Najm R, Xu Q, Jeong DE, Walker D, Balestra ME, Yoon SY, Yuan H et al (2018) Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector. Nat Med 24:647\u2013657","journal-title":"Nat Med"},{"key":"3065_CR30","doi-asserted-by":"publisher","first-page":"5540","DOI":"10.1038\/s41467-020-19264-0","volume":"11","author":"J Zhao","year":"2020","unstructured":"Zhao J, Fu Y, Yamazaki Y, Ren Y, Davis MD, Liu CC, Lu W, Wang X et al (2020) APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer\u2019s disease patient iPSC-derived cerebral organoids. Nat Commun 11:5540","journal-title":"Nat Commun"},{"key":"3065_CR31","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1093\/hmg\/ddx155","volume":"26","author":"J Zhao","year":"2017","unstructured":"Zhao J, Davis MD, Martens YA, Shinohara M, Graff-Radford NR, Younkin SG, Wszolek ZK, Kanekiyo T et al (2017) APOE epsilon4\/epsilon4 diminishes neurotrophic function of human iPSC-derived astrocytes. Hum Mol Genet 26:2690\u20132700","journal-title":"Hum Mol Genet"},{"key":"3065_CR32","doi-asserted-by":"publisher","first-page":"4023","DOI":"10.1523\/JNEUROSCI.3442-16.2017","volume":"37","author":"CC Liu","year":"2017","unstructured":"Liu CC, Hu J, Zhao N, Wang J, Wang N, Cirrito JR, Kanekiyo T, Holtzman DM et al (2017) Astrocytic LRP1 mediates brain A beta clearance and impacts amyloid deposition. J Neurosci 37:4023\u20134031","journal-title":"J Neurosci"},{"key":"3065_CR33","first-page":"1349","volume":"8","author":"H Shimizu","year":"1997","unstructured":"Shimizu H, Julius MA, Giarre M, Zheng Z, Brown AM, Kitajewski J (1997) Transformation by Wnt family proteins correlates with regulation of beta-catenin. Cell Growth Differ 8:1349\u20131358","journal-title":"Cell Growth Differ"},{"key":"3065_CR34","doi-asserted-by":"publisher","first-page":"4157","DOI":"10.1007\/s00018-015-2028-6","volume":"72","author":"N Bengoa-Vergniory","year":"2015","unstructured":"Bengoa-Vergniory N, Kypta RM (2015) Canonical and noncanonical Wnt signaling in neural stem\/progenitor cells. Cell Mol Life Sci 72:4157\u20134172","journal-title":"Cell Mol Life Sci"},{"key":"3065_CR35","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/j.1748-1716.2011.02296.x","volume":"204","author":"P Wend","year":"2012","unstructured":"Wend P, Wend K, Krum SA, Miranda-Carboni GA (2012) The role of WNT10B in physiology and disease. Acta Physiol (Oxf) 204:34\u201351","journal-title":"Acta Physiol (Oxf)"},{"key":"3065_CR36","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.1002\/dvdy.21260","volume":"236","author":"C Schmidt","year":"2007","unstructured":"Schmidt C, McGonnell IM, Allen S, Otto A, Patel K (2007) Wnt6 controls amniote neural crest induction through the non-canonical signaling pathway. Dev Dynam 236:2502\u20132511","journal-title":"Dev Dynam"},{"key":"3065_CR37","doi-asserted-by":"crossref","unstructured":"Chavali M, Klingener M, Kokkosis AG, Garkun Y, Felong S, Maffei A, Aguirre A (2018) Non-canonical Wnt signaling regulates neural stem cell quiescence during homeostasis and after demyelination. Nat Commun 9:36","DOI":"10.1038\/s41467-017-02440-0"},{"key":"3065_CR38","doi-asserted-by":"publisher","first-page":"558155","DOI":"10.3389\/fcell.2020.558155","volume":"8","author":"M Wei","year":"2020","unstructured":"Wei M, Zhang C, Tian Y, Du X, Wang Q, Zhao H (2020) Expression and function of WNT6: from development to disease. Front Cell Dev Biol 8:558155","journal-title":"Front Cell Dev Biol"},{"key":"3065_CR39","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.diff.2012.06.004","volume":"84","author":"R Najdi","year":"2012","unstructured":"Najdi R, Proffitt K, Sprowl S, Kaur S, Yu J, Covey TM, Virshup DM, Waterman ML (2012) A uniform human Wnt expression library reveals a shared secretory pathway and unique signaling activities. Differentiation 84:203\u2013213","journal-title":"Differentiation"},{"key":"3065_CR40","doi-asserted-by":"publisher","first-page":"4289","DOI":"10.1021\/acs.jmedchem.0c01974","volume":"64","author":"ED Bayle","year":"2021","unstructured":"Bayle ED, Svensson F, Atkinson BN, Steadman D, Willis NJ, Woodward HL, Whiting P, Vincent JP et al (2021) Carboxylesterase Notum is a druggable target to modulate Wnt signaling. J Med Chem 64:4289\u20134311","journal-title":"J Med Chem"},{"key":"3065_CR41","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/j.celrep.2013.08.027","volume":"4","author":"J Rios-Esteves","year":"2013","unstructured":"Rios-Esteves J, Resh MD (2013) Stearoyl CoA desaturase is required to produce active, lipid-modified Wnt proteins. Cell Rep 4:1072\u20131081","journal-title":"Cell Rep"},{"key":"3065_CR42","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nature14259","volume":"519","author":"S Kakugawa","year":"2015","unstructured":"Kakugawa S, Langton PF, Zebisch M, Howell SA, Chang TH, Liu Y, Ten FZ, Bineva G et al (2015) Notum deacylates Wnt proteins to suppress signalling activity. Nature 519:187\u2013192","journal-title":"Nature"},{"key":"3065_CR43","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1101\/gad.235473.113","volume":"28","author":"W de Lau","year":"2014","unstructured":"de Lau W, Peng WC, Gros P, Clevers H (2014) The R-spondin\/Lgr5\/Rnf43 module: regulator of Wnt signal strength. Genes Dev 28:305\u2013316","journal-title":"Genes Dev"},{"key":"3065_CR44","doi-asserted-by":"publisher","first-page":"23","DOI":"10.4161\/cc.5.1.2305","volume":"5","author":"KA Kim","year":"2006","unstructured":"Kim KA, Zhao J, Andarmani S, Kakitani M, Oshima T, Binnerts ME, Abo A, Tomizuka K et al (2006) R-spondin proteins: a novel link to beta-catenin activation. Cell Cycle 5:23\u201326","journal-title":"Cell Cycle"},{"key":"3065_CR45","doi-asserted-by":"publisher","first-page":"11452","DOI":"10.1073\/pnas.1106083108","volume":"108","author":"KS Carmon","year":"2011","unstructured":"Carmon KS, Gong X, Lin Q, Thomas A, Liu Q (2011) R-spondins function as ligands of the orphan receptors LGR4 and LGR5 to regulate Wnt\/beta-catenin signaling. Proc Natl Acad Sci USA 108:11452\u201311457","journal-title":"Proc Natl Acad Sci USA"},{"key":"3065_CR46","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nature10337","volume":"476","author":"W de Lau","year":"2011","unstructured":"de Lau W, Barker N, Low TY, Koo BK, Li VS, Teunissen H, Kujala P, Haegebarth A et al (2011) Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling. Nature 476:293\u2013297","journal-title":"Nature"},{"key":"3065_CR47","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/embor.2011.175","volume":"12","author":"A Glinka","year":"2011","unstructured":"Glinka A, Dolde C, Kirsch N, Huang YL, Kazanskaya O, Ingelfinger D, Boutros M, Cruciat CM et al (2011) LGR4 and LGR5 are R-spondin receptors mediating Wnt\/beta-catenin and Wnt\/PCP signalling. EMBO Rep 12:1055\u20131061","journal-title":"EMBO Rep"},{"key":"3065_CR48","doi-asserted-by":"publisher","first-page":"e37137","DOI":"10.1371\/journal.pone.0037137","volume":"7","author":"X Gong","year":"2012","unstructured":"Gong X, Carmon KS, Lin Q, Thomas A, Yi J, Liu Q (2012) LGR6 is a high affinity receptor of R-spondins and potentially functions as a tumor suppressor. PLoS ONE 7:e37137","journal-title":"PLoS ONE"},{"key":"3065_CR49","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nature11019","volume":"485","author":"HX Hao","year":"2012","unstructured":"Hao HX, Xie Y, Zhang Y, Charlat O, Oster E, Avello M, Lei H, Mickanin C et al (2012) ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner. Nature 485:195\u2013200","journal-title":"Nature"},{"key":"3065_CR50","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/nature11308","volume":"488","author":"BK Koo","year":"2012","unstructured":"Koo BK, Spit M, Jordens I, Low TY, Stange DE, van de Wetering M, van Es JH, Mohammed S et al (2012) Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors. Nature 488:665\u2013669","journal-title":"Nature"},{"key":"3065_CR51","doi-asserted-by":"publisher","first-page":"10823","DOI":"10.1074\/jbc.273.18.10823","volume":"273","author":"S Kishida","year":"1998","unstructured":"Kishida S, Yamamoto H, Ikeda S, Kishida M, Sakamoto I, Koyama S, Kikuchi A (1998) Axin, a negative regulator of the wnt signaling pathway, directly interacts with adenomatous polyposis coli and regulates the stabilization of beta-catenin. J Biol Chem 273:10823\u201310826","journal-title":"J Biol Chem"},{"key":"3065_CR52","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/79859","volume":"26","author":"W Liu","year":"2000","unstructured":"Liu W, Dong X, Mai M, Seelan RS, Taniguchi K, Krishnadath KK, Halling KC, Cunningham JM et al (2000) Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin\/TCF signalling. Nat Genet 26:146\u2013147","journal-title":"Nat Genet"},{"key":"3065_CR53","doi-asserted-by":"publisher","first-page":"8520","DOI":"10.1038\/sj.onc.1207892","volume":"23","author":"A Niida","year":"2004","unstructured":"Niida A, Hiroko T, Kasai M, Furukawa Y, Nakamura Y, Suzuki Y, Sugano S, Akiyama T (2004) DKK1, a negative regulator of Wnt signaling, is a target of the beta-catenin\/TCF pathway. Oncogene 23:8520\u20138526","journal-title":"Oncogene"},{"key":"3065_CR54","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1038\/sj.onc.1208303","volume":"24","author":"JM Gonzalex-Sancho","year":"2005","unstructured":"Gonzalex-Sancho JM, Aguilera O, Garcia JM, Pendas-Franco N, Pena C, Cal S, de Herreros AG, Bonilla F et al (2005) The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin\/TCF and is downregulated in human colon cancer. Oncogene 24:1098\u20131103","journal-title":"Oncogene"},{"key":"3065_CR55","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ydbio.2007.04.018","volume":"309","author":"TJ Van Raay","year":"2007","unstructured":"Van Raay TJ, Coffey RJ, Soinica-Krezel L (2007) Zebrafish naked1 and naked2 antagonize both canonical and non-canonical wnt signaling. Dev Biol 309:151\u2013168","journal-title":"Dev Biol"},{"key":"3065_CR56","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1091\/mbc.E14-12-1648","volume":"26","author":"J Larraguibel","year":"2015","unstructured":"Larraguibel J, Weiss AR, Pasula DJ, Dhaliwal RS, Kondra R, Van Raay TJ (2015) Wnt ligand-dependent activation of the negative feedback regulator Nkd1. Mol Biol Cell 26:2375\u20132384","journal-title":"Mol Biol Cell"},{"key":"3065_CR57","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1002\/ijc.24981","volume":"126","author":"S Gotze","year":"2010","unstructured":"Gotze S, Wolter M, Reifenberger G, Muller O, Sievers S (2010) Frequent promoter hypermethylation of Wnt pathway inhibitor genes in malignant astrocytic gliomas. Int J Cancer 126:2584\u20132593","journal-title":"Int J Cancer"},{"key":"3065_CR58","doi-asserted-by":"publisher","first-page":"e18650","DOI":"10.1371\/journal.pone.0018650","volume":"6","author":"TJ Van Raay","year":"2011","unstructured":"Van Raay TJ, Fortino NJ, Miller BW, Ma H, Lau G, Li C, Franklin JL, Attisano L et al (2011) Naked1 antagonizes Wnt signaling by preventing nuclear accumulation of beta-catenin. PLoS ONE 6:e18650","journal-title":"PLoS ONE"},{"key":"3065_CR59","doi-asserted-by":"publisher","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","volume":"26","author":"H Oakley","year":"2006","unstructured":"Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, Guillozet-Bongaarts A, Ohno M et al (2006) Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation. J Neurosci 26:10129\u201310140","journal-title":"J Neurosci"},{"issue":"196","key":"3065_CR60","first-page":"e129","volume":"33","author":"S Jawhar","year":"2012","unstructured":"Jawhar S, Trawicka A, Jenneckens C, Bayer TA, Wirths O (2012) Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal Abeta aggregation in the 5XFAD mouse model of Alzheimer\u2019s disease. Neurobiol Aging 33(196):e129-140","journal-title":"Neurobiol Aging"},{"key":"3065_CR61","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL et al (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families. Science 261:921\u2013923","journal-title":"Science"},{"key":"3065_CR62","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1212\/WNL.43.8.1467","volume":"43","author":"AM Saunders","year":"1993","unstructured":"Saunders AM, Strittmatter WJ, Schmechel D, George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF et al (1993) Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer\u2019s disease. Neurology 43:1467\u20131472","journal-title":"Neurology"},{"key":"3065_CR63","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/s41593-020-0599-5","volume":"23","author":"R Sims","year":"2020","unstructured":"Sims R, Hill M, Williams J (2020) The multiplex model of the genetics of Alzheimer\u2019s disease. Nat Neurosci 23:311\u2013322","journal-title":"Nat Neurosci"},{"key":"3065_CR64","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13024-021-00483-y","volume":"16","author":"BC Farmer","year":"2021","unstructured":"Farmer BC, Williams HC, Devanney NA, Piron MA, Nation GK, Carter DJ, Walsh AE, Khanal R et al (2021) APOEpsilon4 lowers energy expenditure in females and impairs glucose oxidation by increasing flux through aerobic glycolysis. Mol Neurodegener 16:62","journal-title":"Mol Neurodegener"},{"key":"3065_CR65","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13024-020-00382-8","volume":"15","author":"R Larramona-Arcas","year":"2020","unstructured":"Larramona-Arcas R, Gonzalez-Arias C, Perea G, Gutierrez A, Vitorica J, Garcia-Barrera T, Gomez-Ariza JL, Pascua-Maestro R et al (2020) Sex-dependent calcium hyperactivity due to lysosomal-related dysfunction in astrocytes from APOE4 versus APOE3 gene targeted replacement mice. Mol Neurodegener 15:35","journal-title":"Mol Neurodegener"},{"key":"3065_CR66","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.stem.2022.01.007","volume":"29","author":"H Okano","year":"2022","unstructured":"Okano H, Morimoto S (2022) iPSC-based disease modeling and drug discovery in cardinal neurodegenerative disorders. Cell Stem Cell 29:189\u2013208","journal-title":"Cell Stem Cell"},{"key":"3065_CR67","doi-asserted-by":"publisher","first-page":"104724","DOI":"10.1016\/j.nbd.2019.104724","volume":"136","author":"SA Flowers","year":"2020","unstructured":"Flowers SA, Rebeck GW (2020) APOE in the normal brain. Neurobiol Dis 136:104724","journal-title":"Neurobiol Dis"},{"key":"3065_CR68","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1242\/dev.02181","volume":"133","author":"N Prakash","year":"2006","unstructured":"Prakash N, Brodski C, Naserke T, Puelles E, Gogoi R, Hall A, Panhuysen M, Echevarria D et al (2006) A Wnt1-regulated genetic network controls the identity and fate of midbrain-dopaminergic progenitors in vivo. Development 133:89\u201398","journal-title":"Development"},{"key":"3065_CR69","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/1750-1326-6-49","volume":"6","author":"F L'Episcopo","year":"2011","unstructured":"L\u2019Episcopo F, Serapide MF, Tirolo C, Testa N, Caniglia S, Morale MC, Pluchino S, Marchetti B (2011) A Wnt1 regulated Frizzled-1\/beta-catenin signaling pathway as a candidate regulatory circuit controlling mesencephalic dopaminergic neuron-astrocyte crosstalk: therapeutical relevance for neuron survival and neuroprotection. Mol Neurodegener 6:49","journal-title":"Mol Neurodegener"},{"key":"3065_CR70","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1242\/dev.080630","volume":"140","author":"J Yang","year":"2013","unstructured":"Yang J, Brown A, Ellisor D, Paul E, Hagan N, Zervas M (2013) Dynamic temporal requirement of Wnt1 in midbrain dopamine neuron development. Development 140:1342\u20131352","journal-title":"Development"},{"key":"3065_CR71","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1093\/jmcb\/mjt046","volume":"6","author":"W Wurst","year":"2014","unstructured":"Wurst W, Prakash N (2014) Wnt1-regulated genetic networks in midbrain dopaminergic neuron development. J Mol Cell Biol 6:34\u201341","journal-title":"J Mol Cell Biol"},{"key":"3065_CR72","doi-asserted-by":"publisher","first-page":"187","DOI":"10.18632\/aging.100440","volume":"4","author":"YC Shang","year":"2012","unstructured":"Shang YC, Chong ZZ, Wang S, Maiese K (2012) Prevention of beta-amyloid degeneration of microglia by erythropoietin depends on Wnt1, the PI 3-K\/mTOR pathway, Bad, and Bcl-xL. Aging (Albany NY) 4:187\u2013201","journal-title":"Aging (Albany NY)"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-022-03065-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-022-03065-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-022-03065-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T17:49:59Z","timestamp":1701193799000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-022-03065-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,10]]},"references-count":72,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["3065"],"URL":"https:\/\/doi.org\/10.1007\/s12035-022-03065-1","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,10]]},"assertion":[{"value":"21 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were conducted in accordance with NIH guidelines for the care and use of laboratory animals and were reviewed and approved by the Mayo Clinic Institutional Animal Care and Use Committee (IACUC).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable to this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable to this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"G.B. consults for SciNeuro and Lexeo, is on the scientific advisory board for Kisbee, and has consulted for AbbVie, E-Scape, Eisai, and Vida Ventures. Other authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}